1.Clinical Characteristics of Blood Pressure Variability and Cardiac Structure and Function in Patients with Essential Hypertension Complicat-ed with Tumor
Jiaxin LI ; Futian SHI ; Caie LI
Journal of Medical Research 2025;54(2):82-87
Objective To compare the differences in ambulatory blood pressure monitoring(ABPM)parameters and cardiac struc-ture and function indicators in patients with essential hypertension complicated with tumor,then to summarize the relationship between tumor and blood pressure and structural and function of the heart.Methods A retrospective study was conducted to select patients with essential hypertensive admitted to the Second Hospital of Lanzhou University from January 2018 to July 2024.A total of 109 patients with tumor combined with hypertension and 98 patients with hypertension were identified.General information,ABPM parameters,and echo-cardiography results of patients in the two groups were collected,to analyze the differences in ABPM parameters and cardiac structure and function between the two groups.Results Compared with the hypertension group,the tumor combined with hypertension group had a re-duced nighttime systolic blood pressure fall rate,nighttime diastolic blood pressure fall rate,daytime and 24-hour systolic and diastolic blood pressure standard deviations,and left ventricular ejection fraction(all P<0.05),while the left ventricular end-diastolic diameter and interventricular septum thickness were increased(all P<0.05).Pearson correlation analysis revealed that the nighttime systolic blood pressure fall rate was negatively correlated with age,nighttime systolic blood pressure,and morning systolic blood pressure(all P<0.05).In the tumor combined with hypertension patients,the interventricular septum thickness was positively correlated with body mass index,nighttime systolic blood pressure,nighttime diastolic blood pressure,and 24-hour diastolic blood pressure(all P<0.05).Multi-ple linear regression analysis results indicated that tumor and increasing age were independent risk factors for the reduction in nighttime systolic blood pressure fall rate.Conclusion Compared with hypertensive patients,patients with tumor combined with hypertension ex-hibit abnormal blood pressure circadian rhythm,increased left ventricular end-diastolic diameter,thickening of the interventricular sep-tum,and reduced ejection fraction.The presence of tumor and increasing age in patients with essential hypertension are the main risk fac-tors affecting the nighttime blood pressure fall rate.
2.Clinical Characteristics of Blood Pressure Variability and Cardiac Structure and Function in Patients with Essential Hypertension Complicat-ed with Tumor
Jiaxin LI ; Futian SHI ; Caie LI
Journal of Medical Research 2025;54(2):82-87
Objective To compare the differences in ambulatory blood pressure monitoring(ABPM)parameters and cardiac struc-ture and function indicators in patients with essential hypertension complicated with tumor,then to summarize the relationship between tumor and blood pressure and structural and function of the heart.Methods A retrospective study was conducted to select patients with essential hypertensive admitted to the Second Hospital of Lanzhou University from January 2018 to July 2024.A total of 109 patients with tumor combined with hypertension and 98 patients with hypertension were identified.General information,ABPM parameters,and echo-cardiography results of patients in the two groups were collected,to analyze the differences in ABPM parameters and cardiac structure and function between the two groups.Results Compared with the hypertension group,the tumor combined with hypertension group had a re-duced nighttime systolic blood pressure fall rate,nighttime diastolic blood pressure fall rate,daytime and 24-hour systolic and diastolic blood pressure standard deviations,and left ventricular ejection fraction(all P<0.05),while the left ventricular end-diastolic diameter and interventricular septum thickness were increased(all P<0.05).Pearson correlation analysis revealed that the nighttime systolic blood pressure fall rate was negatively correlated with age,nighttime systolic blood pressure,and morning systolic blood pressure(all P<0.05).In the tumor combined with hypertension patients,the interventricular septum thickness was positively correlated with body mass index,nighttime systolic blood pressure,nighttime diastolic blood pressure,and 24-hour diastolic blood pressure(all P<0.05).Multi-ple linear regression analysis results indicated that tumor and increasing age were independent risk factors for the reduction in nighttime systolic blood pressure fall rate.Conclusion Compared with hypertensive patients,patients with tumor combined with hypertension ex-hibit abnormal blood pressure circadian rhythm,increased left ventricular end-diastolic diameter,thickening of the interventricular sep-tum,and reduced ejection fraction.The presence of tumor and increasing age in patients with essential hypertension are the main risk fac-tors affecting the nighttime blood pressure fall rate.
3.An efficacy and safety study of bifidobacterium tetragenous viable bacteria tablets in the treatment of constipation in patients with type 2 diabetes mellitus
Tao YUAN ; Weigang ZHAO ; Yong CAO ; Qi LI ; Minxiu YAO ; Xiuxian HAO ; Hui YU ; Caie JIANG ; Haifang WANG ; Shuping WANG ; Xiaobo WEI ; Wei QIU
Chinese Journal of Internal Medicine 2018;57(4):252-257
Objective The incidence of gastrointestinal symptoms in diabetes is higher than that of non-diabetes.Thus,the aim of the present study was to observe the efficacy and safety of bifidobacterium tetragenous viable bacteria tablets in the treatment of constipation in patients with type 2 diabetes mellitus.Methods This is a multicenter,randomized,double-blind,placebo-controlled,parallel group-comparison clinical research.The subjects were randomly divided into study group and control group according to 1 ∶ 1 ratio by computer generated random number method.The subjects were either treated with bifidobacterium tetragenous viable bacteria tablets (study group) or placebo (control group) for eight weeks,and they were followed up for four weeks without changing foundation therapy for diabetes.The primary outcome was the change of complete spontaneous bowel movements (CSBMs).Results A total of 234 subjects (the study group:116 cases;the control group:118 cases) from 7 centers were included in the present study.The baseline characteristics were comparable between the two groups.In the study group,the CSBMs at 0,2,4,8 and 12 weeks were 0.0(0.0,1.0),1.0(0.5,2.0),2.0(1.0,3.0),3.0(2.0,3.5),2.0(1.0,3.0) times per week,respectively,while the CSBMs of the control group at each corresponding weeks were 0.0(0.0,1.0),1.0(0.0,1.5),1.0(0.0,1.5),1.0(0.0,2.0),1.0(0.0,1.5)times per week,respectively.There is significant difference in CSBMs between the two groups (P<0.05).Moreover,after 12 weeks treatment,the CSBMs over spontaneous bowel movements (SBMs) ratio in the study group was higher than that in the control group [0.53 (0.40,0.67) vs 0.33 (0.00,0.50),P=0.048],indicating a more complete evacuation sensation in the study group.More subjects in the study group (66.38%) reached Bristol stool classification of normal criteria than those in the control group (48.31%,P=0.005).There were significantly improvement of bowel function index in the study group [study group 42.7 (33.3,56.7),control group 60.6 (51.7,75.7),P<0.000 1].Furthermore,the symptoms of constipation was improved,and the satisfaction for the treatment was high in the study group.There were no significant differences of the safety indicators between the two groups.Conclusions Bifidobacterium tetragenous viable bacteria tablets can be used in patients with type 2 diabetes mellitus and constipation.Compared with placebo,it improves constipation and has no obvious adverse effects.
4.Effect of bifidobacterium tetragenous viable bacteria tablets on blood glucose level in patients with type 2 diabetes mellitus
Tao YUAN ; Weigang ZHAO ; Yong CAO ; Qi LI ; Minxiu YAO ; Xiuxian HAO ; Hui YU ; Caie JIANG ; Haifang WANG ; Shuping WANG ; Xiaobo WEI ; Wei QIU
Chinese Journal of Clinical Nutrition 2017;25(4):205-213
Objective To explore the efficacy and safety of bifidobacterium tetragenous viable bacteria tablets (BTVBT) in blood glucose control in patients with type 2 diabetes mellitus (T2DM).Methods This study was a randomized, double-blind, placebo parallel comparison, multicentre clinical research.The subjects were T2DM patients who were using anti-hyperglycemic drugs.They were randomly divided into observation group and control group according to 1∶1 ratio.The subjects accepted the therapy of BTVBT or placebo by oral administration (3 tablets, tid) for eight weeks, followed up for 4 weeks, during which the basic treatment maintained unchanged.The primary outcomes: the changes of glycosylate hemoglobin A1c (HbA1c) from baseline.Results Totally 234 subjects (116 cases in observation group and 118 cases in control group) from 7 centers were included in the study.The baseline characteristics were comparable between these two groups.The HbA1c was (8.00±1.08)% and (7.99±1.03)% in observation group and control group, respectively, at baseline, and was (7.28±1.28)% and (7.36±1.02)% after 12 weeks of treatment [(-0.66±1.38)% vs.(-0.64±1.14)%,P=0.914 5].The secondary outcomes were as follows: the fasting blood glucose (FBG) in the observation group were (7.91±1.87)mmol/L and (8.05±2.33)mmol/L at baseline and after 12 weeks of treatment;while in the control group, the FBG were (8.51±1.68)mmol/L and (8.00±2.02)mmol/L, and comparisons between two groups showed no significant change (P>0.05).The glycated albumin in the observation group and control group were (21.38±5.74)% and (21.93±6.51)% at baseline;after 4 weeks of treatment, they were (20.08±6.05)% and (20.58±7.30)% (the changes from baseline in these two groups were (-1.19±4.37)% and (-1.20±5.08)%];after 8 weeks of treatment, they were (19.07±5.56)% and (20.83±8.74)% [the changes from baseline were (-2.09±4.51)% and (-0.98±6.85)%];after 12 weeks of treatment, they were (19.03±5.19)% and (19.36±6.14)% [the changes from baseline were (-2.18±4.60)% and (-2.47±5.20)%], there were no significant differences between two groups (P>0.05).The subgroup analysis showed that in those patients with the characteristics including body mass index (BMI)≥25 kg/m2 at baseline, the duration of diabetes mellitus longer than 8 years, fasting blood glucose less than 8 mmol/L and using insulin at baseline, the changes of HbA1c from baseline to the end of 12 weeks therapy in the observation group were more than in the control group.There were no significant differences between the two groups in terms of safety profiles, including the vital signs and laboratory findings (blood cell counts, liver function, and kidney function, all P>0.05).Conclusion Administration of BTVBT in T2DM patients for 12 weeks does not remarkably improve the HbA1c.
5.Brief Introduction of the Contribution of Sun Simiao Qianjin Yi Fang to Herbalism
Caie GUO ; Weihong LI ; Xiaoyan LI ; Zengke KONG
China Pharmacy 2016;27(19):2732-2733
OBJECTIVE:To interpret the contribution of Sun Simiao Qianjin Yi Fang to herbalism. METHODS:Using“Sun Simiao”“Qianjin Yi Fang”“herbalism”and other words as key words,related literatures were retrieved from CNKI,Wanfang,Dayi Yixue database and so on during 1983-2015;four aspects explained in Qianjin Yi Fang by Sun Simiao were summarized,involving“herb gathering season ranking the first”“nomen proprium ranking the second”“herb source ranking the third”and“prescription rank-ing the forth”. RESULTS & CONCLUSIONS:More than 50 literatures were collected,including 14 effective literatures. It is the quintessence of precious experience that herbalism is placed in the front of Sun Simiao Qianjin Yi Fang,which greatly contributes to herbalism.“Herb gathering season ranking the first”is the true essence of herb quality guarantee;“nomen proprium ranking the second”guarantees accurate use of herb in the clinic fundamentally;“herb source ranking the third”lays the foundation of therapeu-tic efficacy;“prescription ranking the forth”creates a new era of herb classification by functions.
6.Construction of wild-type and mutant ABCB6-DsRed fusion protein expression vectors
Hongwen LI ; Luzhu CHEN ; Yunhua DENG ; Caie ZHANG
Journal of Medical Postgraduates 2016;29(9):906-909
Objective The mutation of the ABCB6 gene is involved in a variety of diseases , including dyschromatosis univer-salis hereditaria (DUH).This study aimed to construct the expression vectors for the ABCB 6-DsRed fusion proteins, pDsRed-wt-AB-CB6 and pDsRed-L356P-ABCB6, detect its cellular localization in A375 cells, and thus facilitate future studies on the pathogenesis of ABCB6-related diseases . Methods The recombinant plasmids pDsRed-wt/L356 P-ABCB6 were constructed based on the previously constructed pIRES2-ZsGreen1-ABCB6 vector and then transfected into A 375 cells.At 48 hours after transfection , the expression of AB-CB6 was detected by Western blot and the cellular localization of ABCB 6 determined under the laser scanning confocal microscope . Results The expression vectors pDsRed-wt/L356P-ABCB6 were verified by colony PCR, enzyme digestion, and DNA sequencing. The expression of ABCB 6 was significantly increased in the A 375 cells after transfected with the recombinant plasmids .Confocal mi-croscopy showed the localization of both wild-type and mutant ABCB6 in the cytoplasm. Conclusion The expression vectors for wild-type and mutant ABCB6-DsRed fusion protein were successfully constructed and the localization of ABCB 6 in A375 cells was de-termined, which may serve as a basis for further studies of ABCB 6 and the pathogenesis of ABCB 6-related diseases .
7.The effects of basic fibroblast growth factor on neuron-like differentiation of superparamagnetic iron oxide nanoparticles-labeled amniotic membrane-derived mesenchymal stem cell
Guangwei ZENG ; Wanqin GAO ; Gongping WANG ; Huanzhang NIU ; Caie WANG ; Dongpeng LI
Chinese Journal of Radiology 2013;47(12):1139-1143
Objective To study the effect of basic fibroblast growth factor(bFGF) on neuron-like differentiation of superparamagnetic iron oxide nanoparticles (SPIONs)-labeled amniotic membrane-derived mesenchymal stem cell.Methods Cells were cultured from enzymatic-digested amniotic membrane tissue.After that,the following steps were taken:(1) Mesenchymal stem cells derived from amniotic membrane were identified by using cell morphology,MTT method and flow cytometry.(2)SPIONs were used to label amniotic membrane-derived mesenchymal stem.(3)bFGF was imported to induce the neuron-like differentiation of SPIONs-labeled amniotic membrane-derived mesenchymal stem cell.Results (1) Primary cultures of P3,amniotic membrane-derived mesenchymal stem cell were fibroblast-like and expression of surface molecules CD29,CD44,CD90 and CD105 was detected,while expression of CD31,CD34,CD45 and CD106 was negative.(2) SPIONs of no more than 14.0 μg/ml are safe to label amniotic membrane-derived mesenchymal stem cells.Cell activity is more than 80% and expression of surface molecules CD29,CD44,CD90 and CD105 is positive.(3)RT-PCR and immunocytochemistry analysis showed that 10.0 ng/ml bFGF induced neuron-like differentiation of amniotic membrane-derived mesenchymal stem cell (14 μg/ml SPIONs-labeled).Conclusions Enzymatic digestion and cell adherent culture method can be used to isolate mesenchymal stem cells from amniotic membrane.SPIONs of no more than 14.0 μg/ml are safe to label amniotic membrance-derived mesenchymal stem cells and have no effect on the cell activity.Neuron-like differentiation of amniotic membrane-derived mesenchymal stem cell can be induced with 10.0 ng/ml bFGF.
8.Protection effects of Xuezhikang on heart in hypertension patients.
Caie WU ; Ping YE ; Hua DAI ; Hui LI
Clinical Medicine of China 2008;24(11):1109-1113
Objective To investigate the effect of xuezhikang on heart in patients with hypertension. Meth-ods 60 systemic hypertension (HT) patients with normal cholesterol were randomized into placebo group and Xu-ezhikang group (1200 mg/d) for 72 weeks. Extended-released nifedipine were administrated by HT patients. Plasma was obtained at baseline, after 24 weeks and 72 weeks of Xuezhikang therapy. Em/Am ratio at atrioventricular ring , E/A ratio at mitral orifice, IVSTd, LVIDd, LVPWTd were measured by echocardiography. Type Ⅰ collagen car-boxypropeptide (PIP) was determined. Results After 72 weeks treatment, the differences of LVWT, IVSTd, LVP-WTd and LVIDd between Xuezhikang group and the control group were not significant; E/A,Em/Am ratios at atrio-ventricoiar ring were significantly increased except that Em/Am at right atrioventricular ring with right ventricular lateral wall(P <0.01 ,P <0.05). After 24 weeks treatment the levels of plasma PIP were significantly decreased in Xuezhikang group compared with the placebo group (P < 0.01, P < 0.05). Conclusion Xuezhikang exerts cooper-ativity in improving those parameters related to myocardial fibrosis so to protect heart function of hypertension pa-tients.
9.Regional Diastolic Dysfunction of Ventricles in Hypertension Patients
Chinese Journal of Hypertension 2006;0(12):-
LAVP2. Multiple linear regression revealed duration of hypertension, grade of hypertension, age and smoking status were independent determinants for the deterioration of diastolic dysfunction. Conclusion A progressing change in regional diastolic dysfunction from right to left ventricle was found in HT patients. The grade of hypertension and the duration of HT were the major determinants on diastolic dysfunction.
10.Inhibitory effect of anticomplementary protein atrase B from cobra venom on platelet aggregation induced by activated complement
Caie WANG ; Qianyun SUN ; Min LI ; Jingshan SHI
Chinese Pharmacological Bulletin 2003;0(09):-
Aim To investigate the inhibitory effect of atrase B on human platelet aggregation induced by activated complement.Methods By employing CVF to activate complement,the effect of atrase B on gel filtered platelet aggregation induced by activated complement was measured by turbidimetry and the expression of P-selectin and GPⅡb/Ⅲa on platelet membrane were detected by flow cytometry.Results Atrase B inhibited platelet aggregation and the expression of P-selectin and GPⅡb/Ⅲa on platelet membrane induced by activated complement.Conclusion Anticomplementary protein atrase B from Naja atra venom can significantly inhibit platelet activation and aggregation induced by activated complement.

Result Analysis
Print
Save
E-mail